NEW YORK, NY, UNITED STATES, January 12, 2026 /EINPresswire.com/ — Micoy Therapeutics today announced that the NeuroLume™ Test has been granted Breakthrough ...
The approval was supported by a systematic review of published literature that included 46 patients with FOLR1-CFTD treated with leucovorin through various administration routes. The Food and Drug ...
Here are some of the key gynecologic cancer presentations to watch at ASCO 2026.
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results